BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 4286277)

  • 1. Hyperplastic lesions of mouse mammary glands after treatment with 3-methylcholanthrene.
    Faulkin LJ
    J Natl Cancer Inst; 1966 Feb; 36(2):289-97. PubMed ID: 4286277
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of resistance to mammary tumor development in C57BL and I strains of mice. I. Noduligenesis, tumorigenesis, and characteristics of nodules and tumors.
    Nandi S; Haslam S; Helmich C
    J Natl Cancer Inst; 1972 Apr; 48(4):1005-12. PubMed ID: 4336864
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro hormonal requirement for lobulo-alveolar development in the mammary gland of high tumour albino mouse ICRC.
    Ranadive KJ; Gadkari SV; Chapekar TN
    Indian J Exp Biol; 1972 Sep; 10(5):327-32. PubMed ID: 4658181
    [No Abstract]   [Full Text] [Related]  

  • 4. Nodule bioassay of the mouse mammary tumor virus: modifications and quantitative considerations.
    Nandi S; Haslam S; Helmich C; Ritter RI
    J Natl Cancer Inst; 1971 Jun; 46(6):1309-15. PubMed ID: 4325935
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell cycle-related hormone carcinogen interaction during chemical carcinogen induction of nodule-like mammary lesions in organ culture.
    Lin FK; Banerjee MR; Crump LR
    Cancer Res; 1976 May; 36(5):1607-14. PubMed ID: 178426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of effect of prolactin by adrenocorticotropic and growth hormones upon weight and nucleic acids contents of female rat mammary gland.
    Ozegovíc B; Milković S
    J Dairy Sci; 1974 Jan; 57(1):36-40. PubMed ID: 4359195
    [No Abstract]   [Full Text] [Related]  

  • 7. Mammary tumor virus potentiation of endogenous prolactin effect on mammary gland differentiation.
    Ben-David M; Heston WE; Rodbard D
    J Natl Cancer Inst; 1969 Feb; 42(2):207-18. PubMed ID: 4303880
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement by pituitary isografts of mammary hyperplastic nodules in adreno-ovariectomized mice.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1971 Jun; 46(6):1251-5. PubMed ID: 5088047
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1970 Dec; 45(6):1105-12. PubMed ID: 5530649
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of premalignant hyperplasia in methylcholanthrene-induced mammary tumorogenesis.
    Fisher ER; Shoemaker RH; Palekar AS
    Lab Invest; 1975 Oct; 33(4):446-50. PubMed ID: 1186124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nononcogenic hormone-independent alveoli produced by carcinogens in cultured mouse mammary glands.
    Schaefer FV; Tonelli QJ; Dickens MS; Custer RP; Sorof S
    Cancer Res; 1983 Jul; 43(7):3310-5. PubMed ID: 6406057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain differences in response of the mouse mammary gland to hormones in vitro.
    Singh DV; DeOme KB; Bern HA
    J Natl Cancer Inst; 1970 Oct; 45(4):657-75. PubMed ID: 5513496
    [No Abstract]   [Full Text] [Related]  

  • 13. Mammary gland as a morphological end point in carcinogenesis studies.
    Medina D
    J Toxicol Environ Health; 1976 Mar; 1(4):551-60. PubMed ID: 177787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of pituitary-induced nodular hyperplasia in mammary glands of C3H mice fed a phenylalanine-deficient diet.
    Hui YH; DeOme KB; Briggs GM
    J Natl Cancer Inst; 1971 May; 46(5):929-39. PubMed ID: 4333726
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of prolacing and growth hormone on fatty acid synthesis in mouse mammary gland explants in organ culture.
    Wang DY; Hallowes RC; Bealing J; Strong C; Dils R
    J Endocrinol; 1971 Oct; 51(2):xxx-xxxi. PubMed ID: 5121851
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemical carcinogen-induced alveolar nodules in organ culture of mouse mammary gland.
    Banerjee MR; Wood BG; Washburn LL
    J Natl Cancer Inst; 1974 Nov; 53(5):1387-93. PubMed ID: 4473562
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of various oncogenic agents on tumor-producing capabilities of series D BALB-c mammary nodule outgrowth lines.
    Medina D; DeOme KB
    J Natl Cancer Inst; 1970 Aug; 45(2):353-63. PubMed ID: 4324612
    [No Abstract]   [Full Text] [Related]  

  • 18. Urethan-induced mammary tumorigenesis in a murine mammary tumor virus (MuMTV)-positive mouse strain: evidence for a keratinized nodule as an MuMTV-negative precursor lesion for squamous cell tumors.
    Imai S; Tsubura Y; Hilgers J
    J Natl Cancer Inst; 1984 Oct; 73(4):935-41. PubMed ID: 6090751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperplastic and neoplastic changes in the mammary glands of feral mice free of endogenous mouse mammary tumor virus provirus.
    Faulkin LJ; Mitchell DJ; Young LJ; Morris DW; Malone RW; Cardiff RD; Gardner MB
    J Natl Cancer Inst; 1984 Oct; 73(4):971-82. PubMed ID: 6090752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.
    Vomachka AJ; Pratt SL; Lockefeer JA; Horseman ND
    Oncogene; 2000 Feb; 19(8):1077-84. PubMed ID: 10713693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.